AVANOS MEDICAL, INC. (NYSE:AVNS - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Monday . The company traded as low as $11.68 and last traded at $11.77, with a volume of 131178 shares trading hands. The stock had previously closed at $12.35.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen upgraded shares of AVANOS MEDICAL from a "hold" rating to a "buy" rating in a research report on Wednesday, March 19th.
View Our Latest Analysis on AVANOS MEDICAL
AVANOS MEDICAL Trading Down 0.2%
The company has a 50 day simple moving average of $12.43 and a 200 day simple moving average of $14.05. The company has a market capitalization of $566.44 million, a PE ratio of -1.46 and a beta of 1.12. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.56 and a current ratio of 2.57.
AVANOS MEDICAL (NYSE:AVNS - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. AVANOS MEDICAL had a positive return on equity of 6.26% and a negative net margin of 55.80%. The company had revenue of $167.50 million for the quarter, compared to analyst estimates of $161.75 million. During the same quarter last year, the firm posted $0.22 EPS. The firm's revenue for the quarter was up .8% on a year-over-year basis. Analysts anticipate that AVANOS MEDICAL, INC. will post 1.32 earnings per share for the current year.
Institutional Trading of AVANOS MEDICAL
Hedge funds have recently bought and sold shares of the business. Quantbot Technologies LP purchased a new stake in shares of AVANOS MEDICAL in the fourth quarter valued at approximately $64,000. State of Wyoming increased its stake in shares of AVANOS MEDICAL by 132.0% in the 4th quarter. State of Wyoming now owns 5,137 shares of the company's stock worth $82,000 after acquiring an additional 2,923 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in shares of AVANOS MEDICAL by 493.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company's stock worth $129,000 after acquiring an additional 6,714 shares during the last quarter. EP Wealth Advisors LLC raised its holdings in shares of AVANOS MEDICAL by 14.6% during the 4th quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company's stock worth $161,000 after acquiring an additional 1,289 shares during the period. Finally, Heritage Family Offices LLP acquired a new position in shares of AVANOS MEDICAL during the 1st quarter valued at about $146,000. Institutional investors and hedge funds own 95.17% of the company's stock.
AVANOS MEDICAL Company Profile
(
Get Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Read More
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
